MINI-SYMPOSIUM
Endothelial function: 20 years of clinical investigation
Correspondence to:
Correspondence to:
Professor Patrick Vallance
BHF Laboratories, Division of Medicine, University College London, London W1P 9LN, UK; patrick.vallance@ucl.ac.uk
Keywords: endothelial function
| The first 150 words of the full text of this article appear below. |
In 1980 Furchgott and Zawadzki described the phenomenon of endothelium dependent relaxation1 and identified a novel labile relaxant factor later identified as nitric oxide. A few years earlier John Vane and colleagues2 had identified prostacyclin as a potent antiplatelet agent released from endothelial cells. Together these findings stimulated a huge increase in clinical research in vascular mechanisms and endothelial function. Twenty years on it is time to take stock.
The three articles in this mini-symposium place the research on endothelial function in a clinical context. Deanfield and Halcox outline the evidence that changes in endothelium dependent relaxation can be detected even in children and that this may represent the very earliest changes that ultimately lead to atherosclerosis. Hingorani takes this discussion into the realms of nature versus nurture debate by identifying the potential impact of genetic variations in determining key aspects of endothelial function. Finally, Vita addresses the question of
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
